全文获取类型
收费全文 | 315083篇 |
免费 | 31350篇 |
国内免费 | 10987篇 |
专业分类
耳鼻咽喉 | 2041篇 |
儿科学 | 6947篇 |
妇产科学 | 4202篇 |
基础医学 | 63497篇 |
口腔科学 | 6581篇 |
临床医学 | 20528篇 |
内科学 | 51556篇 |
皮肤病学 | 5968篇 |
神经病学 | 25582篇 |
特种医学 | 7705篇 |
外国民族医学 | 90篇 |
外科学 | 23875篇 |
综合类 | 38077篇 |
现状与发展 | 52篇 |
预防医学 | 14449篇 |
眼科学 | 3505篇 |
药学 | 40592篇 |
61篇 | |
中国医学 | 11121篇 |
肿瘤学 | 30991篇 |
出版年
2023年 | 4646篇 |
2022年 | 6150篇 |
2021年 | 12041篇 |
2020年 | 11209篇 |
2019年 | 12794篇 |
2018年 | 12301篇 |
2017年 | 11977篇 |
2016年 | 11517篇 |
2015年 | 13409篇 |
2014年 | 19133篇 |
2013年 | 21274篇 |
2012年 | 18744篇 |
2011年 | 22202篇 |
2010年 | 18545篇 |
2009年 | 17957篇 |
2008年 | 17288篇 |
2007年 | 15620篇 |
2006年 | 13994篇 |
2005年 | 12112篇 |
2004年 | 10650篇 |
2003年 | 9153篇 |
2002年 | 7104篇 |
2001年 | 6201篇 |
2000年 | 5092篇 |
1999年 | 4486篇 |
1998年 | 3564篇 |
1997年 | 3472篇 |
1996年 | 2895篇 |
1995年 | 3107篇 |
1994年 | 2812篇 |
1993年 | 2438篇 |
1992年 | 1935篇 |
1991年 | 1687篇 |
1990年 | 1481篇 |
1989年 | 1203篇 |
1988年 | 1079篇 |
1987年 | 930篇 |
1986年 | 996篇 |
1985年 | 1868篇 |
1984年 | 2016篇 |
1983年 | 1447篇 |
1982年 | 1606篇 |
1981年 | 1328篇 |
1980年 | 1128篇 |
1979年 | 998篇 |
1978年 | 777篇 |
1977年 | 620篇 |
1976年 | 695篇 |
1975年 | 490篇 |
1974年 | 410篇 |
排序方式: 共有10000条查询结果,搜索用时 125 毫秒
991.
目的:分析比较微型种植体支抗与口外弓支抗对安氏Ⅱ类1分类错牙合畸形患者的矫治效果。方法:收集笔者医院95例安氏Ⅱ类1分类错牙合畸形患者临床资料,根据其治疗方法将之分为口外弓支抗(MIA组)46例和微型种植体支抗组(HGA组)49例,比较其矫正前后头影测量结果和模型测量结果,矫治时间和不良反应。结果:治疗后,MIA组牙合平面与SN平面夹角(OP-SN)、上颌中切牙牙长轴与SN平面夹角(U1-SN)、上唇突度、下唇突度、上唇最凸点至E线垂直距离(E line-UL)、下唇最凸点至E线垂直距离(E line-LL)、覆牙合(OB)、覆盖(OJ)均小于HGA组(P<0.05),矫治时间短于HGA组(P<0.05),总不良反应发生率与HGA组差异无统计学意义(P>0.05)。结论:对比HGA,MIA对安氏Ⅱ类1分类错牙合畸形患者的矫治效果更佳,且能够缩短矫治时间。 相似文献
992.
目的 探究葡萄膜炎并发白内障患者晶状体前囊膜中NLRP3炎症小体相关蛋白的表达和前囊膜超微结构改变。方法 随机选取2018年8月至2019年6月在我院诊治的葡萄膜炎并发白内障患者17例(22眼)作为试验组;老年性白内障患者10例(18眼)作为对照组。均于白内障超声乳化手术中环形撕囊获取前囊膜。采用免疫组织化学法检测两组患者晶状体前囊膜NLRP3炎症小体的三个组成结构NLRP3、Caspase-1和接头蛋白ASC的蛋白表达,并对前囊膜进行电镜观察。结果 两组患者晶状体前囊膜中均有NLRP3炎症小体相关蛋白的表达;试验组晶状体前囊膜中NLRP3、Caspase-1及接头蛋白ASC(光密度值分别为0.383±0.067、0.313±0.058、0.335±0.035)表达水平均明显高于对照组(光密度值分别为0.330±0.085、0.271±0.039、0.268±0.036)(均为P<0.05)。试验组患者前囊膜的晶状体上皮细胞可见明显的细胞核固缩,染色质浓缩边集,细胞核膜皱褶、轻度增宽,线粒体形态基本正常、部分线粒体嵴突消失,细胞质中可见典型的凋亡小体。对照组有轻度凋亡改变。结论 NLRP3炎症小体可能参与了葡萄膜炎并发白内障的发病过程,细胞凋亡是葡萄膜炎并发白内障的重要病理改变。 相似文献
993.
【摘要】 报道临床症状不典型的家族性黑棘皮病1家系。先证者女,4岁,自1周岁时,颈部、腹部出现黑色斑片,近年来逐渐扩大至唇周、躯干前部。腹部皮肤全反式共聚焦显微镜检查可见乳头环下延扭曲及沟壑结构,乳头环内可见中高折光颗粒结构。先证者父亲及祖母既往有类似病史,但随着年龄增长色素沉着自发性消退,仅有局部皮纹增粗。采集先证者及父母、祖母外周血,对先证者外周血DNA行Panel靶向测序,结果显示,先证者存在FGFR3基因14号外显子c.1949A>C(p.Lys650Thr)错义突变,Sanger测序验证证实先证者及其父亲和祖母均存在此突变。诊断:家族性黑棘皮病。 相似文献
994.
《Presse medicale (Paris, France : 1983)》2022,51(4):104142
Immunosuppressive agents have enabled the development of allogenic transplantation during the last 40 years, allowing considerable improvement in graft survival. However, several issues remain such as the nephrotoxicity of calcineurin inhibitors, the cornerstone of immunosuppressive regimens and/or the higher risk of opportunistic infections and cancers. Most immunosuppressive agents target T cell activation and may not be efficient enough to prevent allo-immunization in the long term. Finally, antibody mediated rejection due to donor specific antibodies strongly affects allograft survival.Many drugs have been tested in the last decades, but very few have come to clinical use. The most recent one is CTLA4-Ig (belatacept), a costimulation blockade molecule that targets the second signal of T cell activation and is associated with a better long term kidney function than calcineurin inhibitors, despite an increased risk of acute cellular rejection.The research of new maintenance long-term immunosuppressive agents focuses on costimulation blockade. Agents inhibiting CD40-CD40 ligand interaction may enable a good control of both T cells and B cells responses. Anti-CD28 antibodies may promote regulatory T cells. Agents targeting this costimulation pathways are currently evaluated in clinical trials.Immunosuppressive agents for ABMR treatment are scarce since anti-CD20 agent rituximab and proteasome inhibitor bortezomib have failed to demonstrate an interest in ABMR. New drugs focusing on antibodies removal (imlifidase), B cell and plasmablasts (anti-IL-6/IL-6R, anti-CD38…) and complement inhibition are in the pipeline, with the challenge of their evaluation in such a heterogeneous pathology. 相似文献
995.
996.
997.
998.
Chao-Yang Tan Yan-Ping Wang Yuan-Yuan Han Bi-Han Lu Wei Ji Li-Cang Zhu Yang Wang Wen-Yan Shi Li-Ya Shan Liang Zhang Ke-Tao Ma Li Li Jun-Qiang Si 《中国神经再生研究》2020,(5):912-921
Sodium-potassium-chloride cotransporter 1 (NKCC1) and potassium-chloride cotransporter 2 (KCC2) are associated with the transmission of peripheral pain.We investigated whether the increase of NKCC1 and KCC2 is associated with peripheral pain transmission in dorsal root ganglion neurons.To this aim,rats with persistent hyperalgesia were randomly divided into four groups.Rats in the control group received no treatment,and the rat sciatic nerve was only exposed in the sham group.Rats in the chronic constriction injury group were established into chronic constriction injury models by ligating sciatic nerve and rats were given bumetanide,an inhibitor of NKCC1,based on chronic constriction injury modeling in the chronic constriction injury + bumetanide group.In the experiment measuring thermal withdrawal latency,bumetanide (15 mg/kg) was intravenously administered.In the patch clamp experiment,bumetanide (10 μg/μL) and acutely isolated dorsal root ganglion neurons (on day 14) were incubated for 1 hour,or bumetanide (5 μg/μL) was intrathecally injected.The Hargreaves test was conducted to detect changes in thermal hyperalgesia in rats.We found that the thermal withdrawal latency of rats was significantly decreased on days 7,14,and 21 after model establishment.After intravenous injection of bumetanide,the reduction in thermal retraction latency caused by model establishment was significantly inhibited.Immunohistochemistry and western blot assay results revealed that the immune response and protein expression of NKCC1 in dorsal root ganglion neurons of the chronic constriction injury group increased significantly on days 7,14,and 21 after model establishment.No immune response or protein expression of KCC2 was observed in dorsal root ganglion neurons before and after model establishment.The Cl^– (chloride ion) fluorescent probe technique was used to evaluate the change of Cl^– concentration in dorsal root ganglion neurons of chronic constriction injury model rats.We found that the relative optical density of N-(ethoxycarbonylmethyl)-6-methoxyquinolinium bromide (a Cl^– fluorescent probe whose fluorescence Cenintensity decreases as Cl– concentration increases) in the dorsal root ganglion neurons of the chronic constriction injury group was significantly decreased on days 7 and 14 after model establishment.The whole-cell patch clamp technique revealed that the resting potential and action potential frequency of dorsal root ganglion neurons increased,and the threshold and rheobase of action potentials decreased in the chronic constriction injury group on day 14 after model establishment.After bumetanide administration,the above indicators were significantly suppressed.These results confirm that CCI can induce abnormal overexpression of NKCC1,thereby increasing the Cl^– concentration in dorsal root ganglion neurons;this then enhances the excitability of dorsal root ganglion neurons and ultimately promotes hyperalgesia and allodynia.In addition,bumetanide can achieve analgesic effects.All experiments were approved by the Institutional Ethics Review Board at the First Affiliated Hospital,College of Medicine,Shihezi University,China on February 22,2017 (approval No.A2017-169-01). 相似文献
999.
1000.
《Arab Journal Of Gastroenterology》2020,21(2):80-84
Background and study aimsHepatocellular carcinoma (HCC) is a major cause of cancer mortality worldwide. Talin-1 was previously proposed as a potential novel biomarker for HCC diagnosis but with limited and inconsistent data. We aimed to study the possible role of talin-1 in diagnosis and prognostic stratification of patients with hepatocellular carcinoma.Patients and methodsNinety-six patients were recruited and classified into three groups; 1) cirrhosis group: 40 patients with liver cirrhosis, 2) HCC group: 40 patients with HCC, 3) control group: 16 healthy volunteers with matched age and sex. Serum talin-1 level was detected using enzyme-linked immunosorbent assay (ELISA).ResultsThe highest levels of talin-1 were observed among the HCC group followed by cirrhosis then control groups (p = 0.000). In the HCC group, a significant correlation was found between talin-1 and each of multifocal HCC (p = 0.013), portal vein invasion (p = 0.022) and presence of ascites (p = 0.001), while no significant correlation was detected with tumour foci size (p = 0.605). For HCC detection, talin-1 had AUC = 0.858, 100% sensitivity and 65% specificity, while AFP had AUC = 1.000, 100% sensitivity and specificity.ConclusionTalin-1 is a potential marker for diagnosis and prognostic assessment of HCC. Further studies are needed to investigate the ultimate diagnostic and prognostic utility of serum talin-1. 相似文献